DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Nidan Laboratories and Healthcare Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·14 Oct 2026, 8:32 am

Nidan Laboratories and Healthcare

Nidan Laboratories and Healthcare Limited has informed the stock exchanges that it has obtained a certificate of compliance under SEBI's Depositories and Participants Regulations, 2018. This regulatory document confirms that the company's shares are fully dematerialized and that the company adheres to the necessary procedures for maintaining its securities in electronic form.

For investors, this news is largely procedural and serves as a standard compliance update. It confirms that the company's shareholding structure is accurate and that there are no discrepancies in the electronic transfer of shares. This transparency helps maintain trust in the company's corporate governance practices.

Investors should note that this is a routine regulatory filing and does not indicate any material change in the company's business operations or financial health. The focus should remain on the company's core performance metrics and future growth prospects.